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Table 1: Patient Demographics (n = 5)
Figure 1: Adverse Drug Event-Hypoglycemia on an Internal Medicine Unit
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• Hypoglycemia has been identified as one of the
most common preventable adverse drug events
(ADEs) in the hospital setting.
• Hospitalized patients are an especially vulnerable
population and need carefully balanced blood
glucose levels.
• Hyperglycemia may lead to
decrease wound healing time and
affect the immune response.1
• Hypoglycemia may lead to
prolonged hospital stay, poor
prognosis, and death.1
• Studies have linked intensive blood glucose
control with an increase in mortality rates. and
the American Diabetes Association
(ADA) recommends less stringent goal of 140-180
mg/dL in most patients who are hospitalized.
• The Washingt n State Hospital Association
(WSHA) has identified preventing hypoglycemia
event (defined as a blood glucose level of less than
50 mg/dL) through multidisciplinary coordination
as a high priority.2
• Providence Health System has adopted the WSHA
goal of reducing hypoglycemic events to less than
or equal to 4.5% events per month.
• In 2019, the selected large tertiary hospital had an
overall hypoglycemia score of 2.93% with an
individual score of 3.82% on the medical A unit
with 26 patients with a blood glucose < 50 mg/dL
out of total of 680 patients inpatient on insulin or
oral agents. Although the hospital is still below the
goal of less than 4.5% there is always room for
improvement.
• Clinical pharmacists are well-equipped to provide
meaningful interventions in collaboration with
physicians and nurses to improve patient care
outcomes and reduce overall episodes of
hypoglycemia.
Next Steps
• Continue data collection on hypoglycemic
events, interventions made, and acceptance of
interventions.
• Potential to develop a collaborative practice
agreement allowing pharmacists to assist in the
management of inpatient glycemic control.
• Develop education for nursing and pharmacists on
common pitfalls to avoid with glucose management.
Purpose
• The objective of this study is to evaluate the
impact of medication-related interventions made
by pharmacists and pharmacy students on an
internal medicine unit at a large tertiary medical
center in reducing the number of hypoglycemic
events on the unit.
• This study will also evaluate to what degree
medication-related recommendations were
implemented by the hospitalists and the effect on
repeat hypoglycemia events in patients with
previous hypoglycemic events over the course of
the patient’s hospital stay.
Preliminary Results
Health & Services
Demographic Patient A Patient B Patient C Patient D Patient E
Age 66 45 53 29 76
Gender Female Male Male Female Female
Diabetes Type Type 2
Type 2 (new 
onset)
LADA Type 1 Type 2
A1c 7.6% 9.7% 8.2% 13.3% 5.8%
Blood glucose 
level














Lispro 18 units 
at breakfast, 
14 units at 
lunch, 14 units 
at dinner
n/a
























Lispro 18 units 
at breakfast, 
14 units at 
lunch, 5 units 
at dinner
+ moderate SSI





















Lispro 10 units 
TID
Moderate SSI Low SSI Low SSI n/a
BID: twice daily; LADA: latent autoimmune diabetes SSI: sliding scale insulin; PTA: prior to admission 
This study is exempt by Institutional Review Board
Study Design:
• A protocol for pharmacists, residents, and students
to review episodes of hypoglycemia on an internal
medicine unit and provide interventions for
prevention of recurrent events.
• Retrospective chart review of interventions made by
pharmacists from the pilot on one internal medicine
unit.
Study period:
• February 2021 – May 2021
Inclusion Criteria:
• Adults >18
• Receiving insulin or other antihyperglycemic 
medications
• A blood glucose level of < 70 mg/dL
Exclusion criteria:
• Children or adolescents < 18 years
• Insulin pump that is continued while inpatient. 
Patients who were admitted with hypoglycemia, 
unless blood glucose falls below 70 mg/dL after 
being stabilized
• Blood glucose readings outside of the designated 




• The pilot project went live February 12th, 2021.
• Daily profile review by pharmacists of patient with a
blood glucose of 70 mg/dL or less and
recommendations made via MD page or progress
note.
• Initial data shows that there continues to be room
for improvement in hypoglycemic events on an
internal medicine unit.
• Pharmacist interventions were accepted on three
out of five patients identified on the internal
medicine unit.
Limitations
• Control group with which to compare data is
not available.
• The study has not yet reached the sample
size required for adequate power to assess
significance.
• Study period of three months may not have
allowed adequate time for accurate assessment
of pharmacist interventions.
• COVID-19 pandemic may influence number of
possible events.
Number of patients with a blood glucose < 50 mg/dL out of total number of in inpatients 
on insulin or oral agents*
Nov-20: 2 out of 60 ; Dec-20: 3 out of 82; Jan-21: 5 out of 74; Feb-21: 4 out of 84; March-
21: 0 out of 66
* Repeat BG events < 50 within 30 minutes of previous event excluded
